- Last edited on July 18, 2023
Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Previous revision | ||
cl:0-autoimmune-encephalitis:hashimotos [on August 26, 2019] |
cl:0-autoimmune-encephalitis:hashimotos [on August 26, 2019] |
||
---|---|---|---|
Line 25: | Line 25: | ||
The clinical presentation of HE can include seizures, myoclonus, hallucinations, and stroke-like episodes with normal or non-specific CSF and brain MRI abnormalities. | The clinical presentation of HE can include seizures, myoclonus, hallucinations, and stroke-like episodes with normal or non-specific CSF and brain MRI abnormalities. | ||
</callout> | </callout> | ||
+ | <callout type="question" title="Controversial Diagnosis" icon="true"> | ||
+ | Hashimoto’s encephalopathy should be diagnosed only when a thorough clinical assessment has been performed, including comprehensive testing for well characterized neuronal antibodies, and ruling out other potential causes of encephalopathy or encephalitis. In essence, it should be a diagnosis of exclusion.</callout> | ||
</WRAP> | </WRAP> | ||
</WRAP> | </WRAP> | ||
Line 37: | Line 39: | ||
</WRAP> | </WRAP> | ||
<WRAP half column> | <WRAP half column> | ||
- | <callout type="warning" title="Antibodies Are Non-Specific!" icon="true"> | + | <callout type="warning" title="Thyroid Antibodies Are Non-Specific!" icon="true"> |
Thyroid antibodies are not specific for Hashimoto’s encephalopathy. They can be present in up to 13% of healthy individuals, and up to 27% in white women older than 60 years. It can also be present in other autoimmune encephalitis disorders. | Thyroid antibodies are not specific for Hashimoto’s encephalopathy. They can be present in up to 13% of healthy individuals, and up to 27% in white women older than 60 years. It can also be present in other autoimmune encephalitis disorders. | ||
</callout> | </callout> |